<HTML xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en" dir="ltr">
<style type="text/css">
A:before { content:' '; } 
A:after { content:' '; } 
SPAN:before { content:' '; } 
SPAN:after { content:' '; } 
</style>
<BODY class="mediawiki  ltr ns-0 ns-subject page-Team_NTNU-Trondheim_novelapproach"><DIV id="globalWrapper"><DIV id="top-section"><DIV id="p-logo"><A href="/Main_Page" title="Main Page">&quot;
	    </A></DIV><DIV id="menubar" class="left-menu noprint"><UL><LI class="selected"><A href="/Team:NTNU-Trondheim/novelapproach">Page               </A></LI><LI class="new"><A href="/wiki/index.php?title=Talk:Team:NTNU-Trondheim/novelapproach&amp;action=edit&amp;redlink=1">Discussion               </A></LI><LI><A href="/wiki/index.php?title=Team:NTNU-Trondheim/novelapproach&amp;action=edit">View source               </A></LI><LI><A href="/wiki/index.php?title=Team:NTNU-Trondheim/novelapproach&amp;action=history">History               </A></LI><LI style="color:white;cursor:default">teams</LI></UL></DIV><DIV class="right-menu noprint" id="menubar"><UL><LI id="pt-login"><A href="/wiki/index.php?title=Special:UserLogin&amp;returnto=Team:NTNU-Trondheim/novelapproach" title="You are encouraged to log in; however, it is not mandatory [o]" accesskey="o">Log in</A></LI></UL></DIV><DIV id="search-controls" class="noprint"><FORM action="/Special:Search" id="searchform"> </FORM></DIV></DIV><DIV id="content"><H1 class="firstHeading">Team:NTNU-Trondheim/novelapproach</H1><DIV id="bodyContent"><H3 id="siteSub" class="noprint">From 2013.igem.org</H3><P><TITLE>Trondheim iGEM 2013 </TITLE></P><DIV class="layout-1000"><DIV class="row"><DIV id="cssmenu"><UL><LI class="active"><A href="https://2013.igem.org/Team:NTNU-Trondheim"><SPAN>Home</SPAN></A></LI><LI class="has-sub"><A href="#"><SPAN>Project</SPAN></A></LI><LI><A href="https://2013.igem.org/Team:NTNU-Trondheim/Project"><SPAN>Project description</SPAN></A></LI><LI><A href="https://2013.igem.org/Team:NTNU-Trondheim/novelapproach"><SPAN>A novel approach</SPAN></A></LI><LI><A href="https://2013.igem.org/Team:NTNU-Trondheim/Model"><SPAN>Modelling</SPAN></A></LI><LI><A href="https://2013.igem.org/Team:NTNU-Trondheim/Experiments_and_Results"><SPAN>Experiments and Results</SPAN></A></LI><LI><A href="https://2013.igem.org/Team:NTNU-Trondheim/Parts"><SPAN>BioBrick Parts</SPAN></A></LI><LI class="last"><A href="https://2013.igem.org/Team:NTNU-Trondheim/Acknowledgements"><SPAN>Acknowledgements</SPAN></A></LI></UL><LI class="has-sub"><A href="#"><SPAN>Technical Stuff</SPAN></A></LI><LI><A href="https://2013.igem.org/Team:NTNU-Trondheim/Notebook"><SPAN>Notebooks</SPAN></A></LI><LI><A href="https://2013.igem.org/Team:NTNU-Trondheim/Protocols"><SPAN>Protocols</SPAN></A></LI><LI><A href="https://2013.igem.org/Team:NTNU-Trondheim/Primers"><SPAN>Primers</SPAN></A></LI><LI class="last"><A href="https://2013.igem.org/Team:NTNU-Trondheim/Safety"><SPAN>Safety</SPAN></A></LI><LI class="has-sub"><A href="#"><SPAN>Team</SPAN></A></LI><LI><A href="https://2013.igem.org/Team:NTNU-Trondheim/Team"><SPAN>Meet the team</SPAN></A></LI><LI class="last"><A href="https://igem.org/Team.cgi?id=1082"><SPAN>Official Team Profile</SPAN></A></LI><LI class="has-sub"><A href="https://2013.igem.org/Team:NTNU-Trondheim/Outreach"><SPAN>Outreach</SPAN></A></LI><LI class="has-sub"><A href="#"><SPAN>Judging</SPAN></A></LI><LI><A href="https://2013.igem.org/Team:NTNU-Trondheim/Achievements"><SPAN>Achievements</SPAN></A></LI><LI class="last"><A href="https://2013.igem.org/Team:NTNU-Trondheim/Medalcriteria"><SPAN>Medal criteria</SPAN></A></LI><LI class="last"><A href="https://2012.igem.org/Team:NTNU_Trondheim/Matchmaker"><SPAN>Matchmaker</SPAN></A></LI></DIV></DIV><DIV class="row"><DIV class="col12-2"><DIV class="col8" align="justify" style="background-color:#C3A7F3;&gt;
&lt;p style=" text-align:center=""><B> Engineered vesicles is a novel technology within medicine </B></DIV></DIV></DIV><DIV class="row"><DIV class="col12-2" align="justify"><P> 
In the previous years there has been several iGEM teams (some of them are <A href="”https://2012.igem.org/Team:HKUST-Hong_Kong“"> the 2012 HKUST-Hong_Kong  team</A>,  <A href="https://2012.igem.org/Team:NTNU_Trondhei"> the 2012 NTNU_Trondheim team</A> and  <A href="“https://2011.igem.org/Team:BYU_Provo“"> the 2011 BYO_Provo team</A>) that has had their main focus on treating or detecting cancer by introducing engineered bacteria into the human body. Although these biological systems are interesting and valuable on their own, introducing microorganisms that are capable of replicating into the blood stream is highly risky.

We believe that bacterial outer membrane vesicles (OMVs) is a much safer method for treating cancer and other diseases that are in need of a drug delivery vehicle. The focus within medical research on drug delivery vehicles today is mainly within nano medicine and the use of synthetically produced vehicles. There exist very few applications of this technology on the market as it has proven to be difficult to engineer a drug delivery vehicle that meets all of the necessary criteria. Some of these criteria include being stable in the bloodstream (by not being detected by immune cells), being able to recognize the target cells, have the ability to engulf into target cells, being nano sized (to prevent clogging in the blood vessels) and having a drug on/inside the vehicle.  Many pathogenic bacteria such as <I>Pseudomonas aeruginosa</I> and enterogenic <I>Escherichia coli</I> naturally produce OMVs that meets many of these criteria. These OMVs contains toxic compounds and proteases and have the ability to associate and internalize themselves into eukaryotic cells (see figure 1) <A href="http:http://www.ncbi.nlm.nih.gov/pubmed/15549136">[1]</A> . OMVs has in addition an appropriate size 20-250 nm <A href="http://www.ncbi.nlm.nih.gov/pubmed/20825345">[2]</A> . The OMVs will be unable to replicate and is therefore a much safer option then introducing live bacteria into the blood stream.</P><DIV class="col4" style="background-color:white;&gt;&lt;a href=" https:=""><P style="text-align:center; color:black; "><B>Figure 1:</B> Gold labeled vesicles from enterogenic  <I>E.coli</I> that binds and internalizes in HT29 cancer cells <A href="http:http://www.ncbi.nlm.nih.gov/pubmed/15549136">[1]</A>.</P></DIV></DIV><DIV class="row"><DIV class="col12-2" align="justify"><P>
It is our opinion that engineering bacterial OMVs to create drug delivery vehicles is a far too uninvestigated subject. OMVs as drug delivery vehicles is a highly novel approach to treat diseases such as cancer and is a far safer way of treating illness then introducing live bacteria. In order use OMVs as a treatment they need to be engineered. They need to be stable in the blood stream and they need target specific cells. We suggest introducing protein G (see <A href="http://www.ncbi.nlm.nih.gov/pubmed/20825345">project description</A>).
We want, with our wiki, iGEM presentation and poster, to spread the knowledge of bacterial OMV and their potential within medicine. We believe that engineered OMV could be a potential medical treatment in the future if further investigated!</P></DIV></DIV></DIV><DIV class="printfooter">
Retrieved from &quot;<A href="http://2013.igem.org/Team:NTNU-Trondheim/novelapproach">http://2013.igem.org/Team:NTNU-Trondheim/novelapproach</A>&quot;</DIV></DIV></DIV><DIV id="footer-box" class="noprint"><DIV id="footer"><UL id="f-list"><LI id="t-recentchanges"><A href="/Special:RecentChanges" title="Recent changes">Recent changes</A></LI><LI id="t-whatlinkshere"><A href="/Special:WhatLinksHere/Team:NTNU-Trondheim/novelapproach" title="List of all wiki pages that link here [j]" accesskey="j">What links here</A></LI><LI id="t-recentchangeslinked"><A href="/Special:RecentChangesLinked/Team:NTNU-Trondheim/novelapproach" title="Recent changes in pages linked from this page [k]" accesskey="k">Related changes</A></LI><LI id="t-specialpages"><A href="/Special:SpecialPages" title="List of all special pages [q]" accesskey="q">Special pages</A></LI><LI><A href="/Special:Preferences">My preferences</A></LI></UL></DIV><DIV id="footer"><UL id="f-list"><LI id="t-print"><A href="/wiki/index.php?title=Team:NTNU-Trondheim/novelapproach&amp;printable=yes" title="Printable version of this page [p]" accesskey="p">Printable version</A></LI><LI id="t-permalink"><A href="/wiki/index.php?title=Team:NTNU-Trondheim/novelapproach&amp;oldid=303364" title="Permanent link to this revision of the page">Permanent link</A></LI><LI id="privacy"><A href="/2013.igem.org:Privacy_policy" title="2013.igem.org:Privacy policy">Privacy policy</A></LI><LI id="disclaimer"><A href="/2013.igem.org:General_disclaimer" title="2013.igem.org:General disclaimer">Disclaimers</A></LI></UL></DIV></DIV></DIV></DIV></BODY></HTML>